Raxtozinameran

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Raxtozinameran
DrugBank Accession Number
DB18228
Background

Not Available

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Other vaccines
Synonyms
  • Comirnaty Omicron XBB.1.5

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
ComirnatyInjection, suspension0.048 mg/0.48mLIntramuscularPfizer Laboratories Div Pfizer Inc2023-09-11Not applicableUS flag
ComirnatyInjection, suspension0.043 mg/0.432mLIntramuscularPfizer Laboratories Div Pfizer Inc2023-09-112024-06-30US flag
ComirnatyInjection, suspension0.042 mg/0.418mLIntramuscularPfizer Laboratories Div Pfizer Inc2023-10-31Not applicableUS flag
Comirnaty Omicron XbB.1.5Suspension3 mcg / 0.2 mLIntramuscularBiontech Manufacturing Gmbh2023-10-24Not applicableCanada flag
Comirnaty Omicron XbB.1.5Suspension30 mcg / 0.3 mLIntramuscularBiontech Manufacturing Gmbh2023-10-10Not applicableCanada flag

Categories

Drug Categories
Not Available
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available

References

General References
Not Available
RxNav
2664825

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4TerminatedPreventionCancer / Coronavirus Disease 2019 (COVID‑19)1
Not AvailableActive Not RecruitingNot AvailableAnesthetics Adverse Reaction / Coronavirus Disease 2019 (COVID‑19) / Safety / Vaccines1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, suspensionIntramuscular0.042 mg/0.418mL
Injection, suspensionIntramuscular0.043 mg/0.432mL
Injection, suspensionIntramuscular0.048 mg/0.48mL
SuspensionIntramuscular10.00 mcg
SuspensionIntramuscular10 mcg / 0.3 mL
SuspensionIntramuscular10 mcg / 0.2 mL
SuspensionIntramuscular3 mcg / 0.2 mL
SuspensionIntramuscular30 mcg / 0.3 mL
Injection, suspensionIntramuscular0.0158 mg/0.48mL
Injection, suspensionIntramuscular0.0158 mg/1.58mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created at September 14, 2023 16:26 / Updated at September 15, 2023 10:39